National Bank of Canada’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,581
Closed -$44.4K 2797
2023
Q2
$44.4K Sell
1,581
-9,475
-86% -$235K ﹤0.01% 1807
2023
Q1
$247K Sell
11,056
-1,078
-9% -$28.2K ﹤0.01% 1358
2022
Q4
$322K Sell
12,134
-3,504
-22% -$114K ﹤0.01% 1356
2022
Q3
$442K Sell
15,638
-445
-3% -$11.4K ﹤0.01% 1191
2022
Q2
$335K Buy
16,083
+12,218
+316% +$229K ﹤0.01% 1285
2022
Q1
$84K Buy
3,865
+3,677
+1,956% +$79.8K ﹤0.01% 1711
2021
Q4
$4K Buy
+188
New +$4.56K ﹤0.01% 2567

Other funds holding CCRN

National Bank of Canada's CCRN Position: Q3 2023 in Review

National Bank of Canada sold out of Cross Country Healthcare (CCRN) in Q3 2023, closing a stake of 1,581 shares — an estimated $44.4K sold.

National Bank of Canada first reported a position in CCRN in Q4 2021 and held it in 7 quarters. The position peaked at $442K in Q3 2022. 189 funds tracked by Wall St. Rank hold CCRN as of Q3 2023.

  • National Bank of Canada reported no remaining Cross Country Healthcare position as of Q3 2023 after selling out during the quarter.
  • National Bank of Canada sold 1,581 Cross Country Healthcare shares in Q3 2023, an estimated $44.4K.
  • National Bank of Canada first reported a position in Cross Country Healthcare in Q4 2021 and held it in 7 quarters.
  • National Bank of Canada's Cross Country Healthcare position peaked at $442K in Q3 2022.
  • 189 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2023.

Based on National Bank of Canada's 13F filing for Q3 2023, filed 10 Oct 2023.